Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

Anne M. Szostak, a director at IDEXX Laboratories Inc. (NASDAQ:IDXX), recently sold 3,000 shares of the company's common stock. The shares were sold at an average price of $465.945, totaling ...

Piper Sandler raised the firm’s price target on Idexx Laboratories (IDXX) to $510 from $435 and keeps a Neutral rating on the shares. The firm ...

Investors in IDEXX Laboratories, Inc. IDXX need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 21, 2025 $290.00 Call had some of the highest ...

Piper Sandler analyst David Westenberg maintained a Hold rating on Idexx Laboratories (IDXX – Research Report) today and set a price target of ...

IDEXX Laboratories is poised for growth in the pet healthcare market. Check out why I see a 50% upside in IDXX stock by FY27.

Shares of IDEXX Laboratories Inc. IDXX rallied 1.12% to $464.91 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.67% to ...

Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.

Idexx delivered revenue and EPS growth of 6% and 13% in Q4, but its guidance appears to have caught the market's attention. Looking ahead to 2025, management expects the company to grow sales by 4 ...

Shares of IDEXX Laboratories Inc. IDXX slipped 1.71% to $460.56 Thursday, on what proved to be an all-around mixed trading ...

Spire Wealth Management trimmed its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 86.8% ...

IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to ...